Puma Biotechnology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Puma Biotechnology, Inc. (PBYI) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.070.080.080.060.090.120.17
Short-Term Investments0.030.010.000.020.010.000.00
Cash & Short-Term Investments0.100.100.080.080.090.120.17
Accounts Receivable0.030.050.040.030.030.030.02
Inventory0.010.010.000.010.000.000.00
Other Current Assets0.000.000.000.000.000.000.00
Total Current Assets0.150.160.130.140.150.170.20
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.010.020.020.020.00
Intangible Assets0.050.060.070.070.070.000.00
Other Non-Current Assets0.000.000.000.000.000.000.01
Total Non-Current Assets0.070.070.090.090.100.070.06
Total Assets0.210.230.220.230.240.230.26
Current Liabilities
Accounts Payable0.010.010.060.010.070.090.06
Short-Term Debt0.050.030.000.000.010.000.00
Current Portion of Long-Term Debt0.050.030.000.000.010.000.00
Accrued Liabilities0.020.040.030.080.030.000.00
Other Current Liabilities0.000.000.000.000.000.000.00
Total Current Liabilities0.100.100.080.110.110.090.07
Non-Current Liabilities
Long-Term Debt0.020.070.110.100.100.120.15
Other Non-Current Liabilities0.000.000.010.010.020.000.00
Total Non-Current Liabilities0.030.080.130.120.150.130.16
Total Liabilities0.120.180.200.230.250.220.22
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.31-1.35-1.37-1.37-1.34-1.28-1.20
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.411.401.391.361.331.301.24
Shares Outstanding0.050.050.050.040.000.000.00
Total Stockholders' Equity0.090.050.020.00-0.010.020.03
Total Liabilities & Equity0.210.230.220.230.240.230.26